Discover 1,308 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,308
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Gahanna OH, Indianapolis IN, Roanoke VA, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Neoplasms
Location: Gahanna OH, Centerville OH, Pittsburgh PA, Carmel IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06919965
Phase 3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Gahanna OH, Cincinnati OH, Morgantown WV, Detroit MI,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase 3, Recruiting
Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
for
Prostate Cancer (Diagnosis)
Location: Columbus OH
Sponsor: Central Ohio Urology Group
Sex: Male
Age: 18+
Code: NCT07875192
Recruiting
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
for
Prostate Cancer (Adenocarcinoma), Prostate CA, Prostate Cancers,
Location: Gahanna OH, Myrtle Beach SC
Sponsor: Cellvax Therapeutics Inc
Sex: Male
Age: 0+
Code: NCT06636682
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Gahanna OH, Greenwood IN, London, Chicago IL, Hamilton,
Sponsor: Theralase® Technologies Inc.
Sex: All
Age: 18+
Code: NCT03945162
Phase 2, Recruiting
Electroencephalogram (EEG) Enhanced Transcranial Magnetic Stimulation (eTMS) for Chronic Trauma and Stressor-Related Disorders (TSRD)
for
Trauma and Stressor Related Disorders
Location: Columbus OH
Sponsor: Marcia Bockbrader, MD PhD
Sex: All
Age: 22+
Code: NCT05835414
Phase 2, Phase 3, Recruiting
PULSED AF Post-Approval Study
for
Atrial Fibrillation
Location: Grove City OH, Cincinnati OH, Whitesburg KY, London,
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All
Age: 18+
Code: NCT06578104
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for
Low Grade Serous Ovarian Cancer
Location: Hilliard OH, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Verastem, Inc.
Sex: Female
Age: 18+
Code: NCT06072781
Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Hilliard OH, Lexington KY, Morgantown WV, Detroit MI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase 2, Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Columbus OH, Pittsburgh PA, Chicago IL, Philadelphia PA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT03686124
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)